Ming Gui
Overview
Explore the profile of Ming Gui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Swai J, Gui M, Long M, Wei Z, Hu Z, Liu S
Nephrology (Carlton)
. 2021 Sep;
27(1):7-24.
PMID: 34510645
End-stage renal disease (ESRD) patients are amongst the vulnerable groups and thus prioritized in the Coronavirus disease-2019 vaccination programmes. However, this cohort was excluded from vaccine-trials and yet shares the...
12.
Zhang Y, Gui M, Wang Y, Mani N, Chaudhuri S, Gao B, et al.
Arthritis Rheumatol
. 2021 Jun;
73(12):2314-2326.
PMID: 34105254
Objective: To explore the molecular mechanisms underlying dysregulation of lipid metabolism in the pathogenesis of systemic lupus erythematosus (SLE). Methods: B cells in peripheral blood from patients with SLE and...
13.
Liu Y, Li C, Yang Y, Li T, Xu Y, Zhang W, et al.
Immunol Cell Biol
. 2021 Mar;
99(7):697-710.
PMID: 33655578
Defects causing concomitant loss of CD25 expression in regulatory T cells (Tregs) have been identified in systemic lupus erythematosus (SLE). However, the cause of this deficiency is not fully understood....
14.
Sun J, Liu C, Zhang S, Yi B, Gui M, Zhang W, et al.
Clin Rheumatol
. 2019 Jun;
38(8):2289.
PMID: 31209705
The publisher regret that Funding statement was incomplete in the original publication; the authors have requested that the revised Funding statement be noted.
15.
Sun J, Liu C, Zhang S, Yi B, Gui M, Zhang W, et al.
Clin Rheumatol
. 2019 May;
38(9):2509-2518.
PMID: 31104216
Objective: Systemic lupus erythematosus (SLE) is characterized by uncontrolled production of pro-inflammatory cytokines. Vitamin D receptor (VDR) has potent anti-inflammatory activities. The aim of this study was to examine the...
16.
Zhang Q, Yan L, Chen M, Gui M, Lu L, Deng F, et al.
Cell Biol Int
. 2019 Apr;
43(7):760-769.
PMID: 30958627
Previous studies show that the proliferation of human mesangial cells (HMCs) played a significant part in the pathogenesis of Henoch-Schönlein purpura nephritis (HSPN). The aim of this study was to...
17.
Yang S, Zhang H, Shi S, Zhu Y, Song N, Dai Q, et al.
Curr Med Chem
. 2018 Nov;
27(20):3346-3361.
PMID: 30479205
Background: Systemic Lupus Erythematosus (SLE) is a polysystem autoimmune disease that adversely affects human health. Various organs can be affected, including the kidney or brain. Traditional treatment methods for SLE...
18.
Zhang Q, Guo Q, Gui M, Ren Z, Hu B, Lu L, et al.
BMC Pediatr
. 2018 May;
18(1):159.
PMID: 29751784
Background: Henoch-Schönlein purpura is a common small vessel vasculitis in children. Acute pancreatitis rarely presents as a complication of Henoch-Schönlein purpura and has not been well characterized. Methods: We retrospectively...
19.
Yang S, Liu J, Yi B, Mao J, Zhang X, Liu Y, et al.
Ther Apher Dial
. 2017 Mar;
21(4):387-394.
PMID: 28322017
Microalbuminuria is an early biomarker of kidney injury, the aim of this study was to investigate the impact of high sensitivity C-reactive protein (hs-CRP) on microalbuminuria in adults with cardiovascular...
20.
Sun J, Zhang H, Ji Y, Gui M, Yi B, Wang J, et al.
Int J Clin Exp Med
. 2016 Feb;
8(11):21572-8.
PMID: 26885107
The present study aimed to evaluate the efficacy and safety of combination of cyclophosphamide (CTX) and mycophenolate mofetil (MMF) as induction treatment in Chinese patients with class IV lupus nephritis...